CalciMedica Inc.

Last updated September 27, 2026
Favorite this organization

Organization details

Legal name
CalciMedica Inc.
Former names
Graybug Vision, INC. GRAYBUG, Inc.
Ownership
Public
Status
Active
SIC code
2834 — Pharmaceutical Preparations
Jurisdiction of incorporation
Delaware
Headquarters city
La Jolla
Headquarters state / province
California
Headquarters country
United States
Fiscal year end
December
Ticker symbol
CALC
Primary stock exchange
Nasdaq

Identifiers

SEC CIK
0001534133
EIN
45-2120079

Board of directors

Follow this board

Chief executives

A. Rachel Leheny · CHIEF EXECUTIVE OFFICER
Dates unknown

Director election results

Annual meeting of June 24, 2025. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.

Board connections

3 of this board's directors also sit on 6 other boards.

Network of CalciMedica Inc.'s board connections Cerus Corporation Cerus Corporation LENZ Therapeutics Inc. LENZ Therapeutics Inc. Lantheus Holdings Inc. Lantheus Holdings Inc. Metagenomi Therapeutics Inc. Metagenomi Therapeutic... Surrozen Inc. Surrozen Inc. Zentalis Pharmaceuticals Inc. Zentalis Pharmaceutica... Eric Bjerkholt Eric Bjerkholt Frederic Guerard Frederic Guerard Julia Marie Eastland Julia Marie Eastland CalciMedica Inc.
Shared director Other board Same sector

Insider trades

All notable trades →

From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.

Bought, last 12 months
$199,178
1 purchase by 1 insider
Sold, last 12 months
$0
0 sales by 0 insiders
Date Insider Transaction Shares Price Value
Jun 25, 2026 Fred A. Middleton Director, 10% owner Open-market purchase +248,972 $0.80 $199,178
Jun 25, 2026 Hebbar Sudarshan Officer (Chief Medical Officer) Grant or award +124,486 $0.80 $99,589
Jun 25, 2026 Robert N. Wilson Director Grant or award +1,182,621 $0.80 $946,097
Jun 25, 2026 Eric W. Roberts Director, Officer (CHIEF BUSINESS OFFICER), 10% owner Grant or award +186,729 $0.80 $149,383
Jun 25, 2026 A. Rachel Leheny Director, Officer (CHIEF EXECUTIVE OFFICER), 10% owner Grant or award +186,729 $0.80 $149,383
Sep 18, 2025 Eric W. Roberts Director, Officer (CHIEF BUSINESS OFFICER), 10% owner Open-market purchase +2,500 $3.07 $7,675
Sep 15, 2025 Eric W. Roberts Director, Officer (CHIEF BUSINESS OFFICER), 10% owner Open-market purchase +3,400 $2.68 $9,112
Sep 12, 2025 Eric W. Roberts Director, Officer (CHIEF BUSINESS OFFICER), 10% owner Open-market purchase +5,000 $3.12 $15,600
Sep 9, 2025 Eric W. Roberts Director, Officer (CHIEF BUSINESS OFFICER), 10% owner Open-market purchase +2,343 $3.15 $7,380
Aug 29, 2025 Eric W. Roberts Director, Officer (CHIEF BUSINESS OFFICER), 10% owner Open-market purchase +800 $2.74 $2,192
Aug 28, 2025 Eric W. Roberts Director, Officer (CHIEF BUSINESS OFFICER), 10% owner Open-market purchase +9,200 $2.86 $26,312
Aug 21, 2025 Eric W. Roberts Director, Officer (CHIEF BUSINESS OFFICER), 10% owner Open-market purchase +3,508 $2.79 $9,787
Aug 20, 2025 Eric W. Roberts Director, Officer (CHIEF BUSINESS OFFICER), 10% owner Open-market purchase +2,000 $2.72 $5,440
Aug 20, 2025 Eric W. Roberts Director, Officer (CHIEF BUSINESS OFFICER), 10% owner Option exercise +15,000 $1.53 $22,950
Aug 19, 2025 Eric W. Roberts Director, Officer (CHIEF BUSINESS OFFICER), 10% owner Open-market purchase +1,000 $2.79 $2,790

Reviews (0)

Sign in to write a review.

No reviews yet. Be the first to write one.

We use cookies to run this site and, with your permission, to measure traffic and support the affiliate links that help fund it.